Metformin, which is used for the management of type 2 diabetes, has gained significant attention for its potential longevity benefits based on the results of multiple preclinical and clinical studies.
This project aims to improve the evidence-based scientific data via animal studies.
We have a team of three MD that are experienced associate professors with a strong publication record in high-impact SCI and SCI-E journals.

We are planning several studies to investigate the longevity benefits of metformin.

Currently, our first animal study has received local ethical approval and is in the funding phase.